Overcoming ROS Resistance of Photodynamic Therapy with Self‐Assembled Nano‐Prodrugs for Efficient Triple‐Negative Breast Cancer
Authors:
- 24 October 2023
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (4)
Abstract
Triple‐negative breast cancer (TNBC) is endowed with a highly aggressive nature that results in distant metastases and high recurrence rates, yet limited success is realized in traditional chemotherapy. Activatable photosensitizers (PSs) may provide an effective and non‐invasive strategy to induce TNBC cell death in a precise way by offering stimuli‐responsive reactive oxygen species (ROS). However, the toxicity of ROS is often mitigated and even devitalized by the instinctive behavior of ROS resistance in TNBC cells. To address this issue, herein a small molecular self‐assembly nano‐prodrug is presented to co‐deliver an activatable PS and ROS resistance inhibitor. In TNBC cells, the overexpressed glutathione can disassemble the nano‐prodrug, thereby releasing ROS resistance inhibitor and activating the PS for photodynamic therapy and fluorescence imaging. A hybrid membrane coating‐assisted nanoparticle formation strategy is further demonstrated for efficient inhibition of tumor growth and distant metastases on both subcutaneous and orthotopic TNBC mice models.Keywords
Funding Information
- National University of Singapore (A‐0009163‐01‐00)
- National Research Foundation Singapore (A‐8000939‐00‐00)
- National Natural Science Foundation of China (82073779, 32000992)
This publication has 61 references indexed in Scilit:
- Control of polymeric nanoparticle size to improve therapeutic deliveryJournal of Controlled Release, 2015
- Physical Principles of Nanoparticle Cellular EndocytosisACS Nano, 2015
- Ultrasensitive Near-Infrared Fluorescence-Enhanced Probe for in Vivo Nitroreductase ImagingJournal of the American Chemical Society, 2015
- Toxicology and clinical potential of nanoparticlesNano Today, 2011
- System xc‐ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNSBritish Journal of Pharmacology, 2011
- Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapyBreast Cancer, 2011
- Triple-Negative Breast CancerNew England Journal of Medicine, 2010
- Activatable Photosensitizers for Imaging and TherapyChemical Reviews, 2010
- Size‐Dependent Endocytosis of NanoparticlesAdvanced Materials, 2009
- ROS stress in cancer cells and therapeutic implicationsDrug Resistance Updates, 2004